Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease

NCT03460795 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

BIOLOGICAL: MSC and Tregs

Sponsor

Nanjing Medical University